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The study assumed that the antisaccade (AS) task is a relevant psychophysical tool
to assess (i) short-term neuromodulation of the dorsolateral prefrontal cortex (DLPFC)
induced by intermittent theta burst stimulation (iTBS); and (ii) mood change occurring
during the course of the treatment. Saccadic inhibition is known to strongly involve
the DLPFC, whose neuromodulation with iTBS requires less stimulation time and lower
stimulation intensity, as well as results in longer aftereffects than the conventional
repetitive transcranial magnetic stimulation (rTMS). Active or sham iTBS was applied every
day for 3 weeks over the left DLPFC of 12 drug-resistant bipolar depressed patients. To
assess the iTBS-induced short-term neuromodulation, the saccadic task was performed
just before (S1) and just after (S2) the iTBS session, the first day of each week. Mood was
evaluated through Montgomery and Asberg Depression Rating Scale (MADRS) scores and
the difference in scores between the beginning and the end of treatment was correlated
with AS performance change between these two periods. As expected, only patients from
the active group improved their performance from S1 to S2 and mood improvement was
significantly correlated with AS performance improvement. In addition, the AS task also
discriminated depressive bipolar patients from healthy control subjects. Therefore, the AS
task could be a relevant and useful tool for clinicians to assess if the Transcranial magnetic
stimulation (TMS)-induced short-term neuromodulation of the DLPFC occurs as well as a
“trait vs. state” objective marker of depressive mood disorder.
Keywords: antisaccades, DLPFC, rTMS iTBS, bipolar disorder, short-term neuromodulation, long-term
neuromodulation
INTRODUCTION
rTMS TREATMENT OF DEPRESSION: NECESSITY TO ASSESS THE
INDUCED NEUROMODULATION
Transcranial magnetic stimulation (TMS) is a non-invasive
technique that induces a magnetic field on the skull which changes
rapidly enough to induce electrical currents in underlying cortical
tissue and thus to induce a neuromodulation effect (Hallet, 2000).
Repeated TMS (rTMS) has been used as a therapeutic tool for
the treatment of drug-resistant mood disorders since the 1990s;
patients receive a daily dose of rTMS over frontal regions for
several weeks. The rationale for this treatment is that whereas
a single rTMS session induces an early long-term potentiation
of the targeted cortical area (short-term neuromodulation),
cumulative rTMS sessions induce widespread late long-term
potentiation across multiple neural circuits (Noda et al., 2013).
Meta-analyses of rTMS as a treatment for depression have
been recently published (Janicak et al., 2010; Slotema et al., 2010;
George and Post, 2011; Berlim et al., 2014). All these studies agree
that the therapeutic efficacy of rTMS is statistically significant
but affects few patients. For example, Berlim et al. (2014) showed
that about 30% of depressed patients receiving active excitatory
rTMS responded to the treatment compared to 10% of patients
who received sham treatment (analysis based on 29 studies using
randomized, double-blind and sham-controlled trials).
To improve the therapeutic efficacy of rTMS, a new protocol—
theta burst stimulation (TBS)—(Huang et al., 2005) has been
developed. TBS has been shown not to differ from rTMS in terms
of strength and direction of aftereffects (Thut and Pascual-Leone,
2010; Di Lazzaro et al., 2011) but to exert longer-lasting post-
stimulation effects (Thut and Pascual-Leone, 2010) with less stim-
ulation time and lower stimulation intensity (Hinder et al., 2014).
For these reasons TBS is of particular interest for clinicians, and
recently some studies investigated the therapeutic effectiveness of
TBS for the treatment of mood disorders, using intermittent theta
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burst stimulation (iTBS) that produces long-term potentiation-
like effects, or continuous TBS (cTBS) that produces long-term
depression-like effects. Li et al. (2014) compared cTBS, iTBS and
sham stimulation. They found that depressive mood improved
in all groups, with a better antidepressant effect for iTBS (40%
responders) than for cTBS (25% responders) and sham (13%
responders). Plewnia et al. (2014) compared TBS to sham stim-
ulation. They found that 56% of patients receiving active TBS
responded to the treatment compared to 25% of patients who
received sham treatment. As a whole, these results indicate that
whatever the TMS protocol, the therapeutic efficacy of rTMS is
statistically significant but remains limited, and the rTMS clinical
relevance is still debated (Padberg and George, 2009).
Apart from idiopathic reasons, several technical/neuro-
physiologic factors might account for the lack of TMS efficacy.
For example, the stimulation parameters (intensity, frequency)
might not be adjusted properly for every patient, the dorsolat-
eral prefrontal cortex (DLPFC) might be identified or targeted
incorrectly (Fox et al., 2012), or the TMS treatment might fail
to induce short-term neuromodulation of the DLPFC in some
patients, which prevents the long-term potentiation. To move
forward on these issues, it is crucial to ensure that TMS-induced
neuromodulation of the DLPFC effectively occurs. This question
requires the development of an instrument that can objectively
assess this neuromodulation. To be helpful for clinicians, this
instrument has to be non-invasive and easy to use. We assumed
that an oculometric task such as the antisaccade (AS) task may
provide such a tool (Crevits et al., 2005; Malsert et al., 2012a,b,
2013).
RELEVANCE OF AS TASK TO ASSESS TMS-INDUCED
NEUROMODULATION OF THE DLPFC AND OF MOOD IMPROVEMENT
To perform an AS requires the inhibition of a reflexive saccade
toward a target and the generation of a voluntary saccade in
the opposite direction (Everling and Fischer, 1998). Several lines
of evidence suggest that the DLPFC is involved in a cortical
network underlying the inhibition process required to perform
a correct AS. Some studies showed that lesions of the DLPFC
in humans lead to an increase in inhibition errors during AS
tasks (Pierrot-Deseilligny et al., 2003; Ploner et al., 2005). Elec-
trophysiological and TMS studies confirmed the involvement
of the DLPFC in saccadic inhibition, suggesting a lateralized
inhibitory control of the DLPFC (Müri et al., 1999; Johnston
and Everling, 2006; Wegener et al., 2008; Müri and Nyffeler,
2008; but Nyffeler et al., 2007). As a consequence, studying AS
performance during rTMS treatment applied over the DLPFC,
might inform about the rTMS-induced neuromodulation of this
cortical region. Moreover, some studies showed that a clinical
improvement could result in cognitive improvement. Biringer
et al. (2005) showed that recovery from depression is associated
with a recovery of many aspects of executive functions to a normal
level. Moreover, using rTMS over the left DLPFC on treatment-
resistant depressed patients, Kedzior et al. (2012) found, after
20 days of rTMS treatment, a cognitive improvement for these
patients as well as a mood improvement. As a consequence, we
expected that the saccadic task could also be a marker of mood
improvement.
PILOT STUDY
To test the relevance of AS task to assess TMS-induced neu-
romodulation of the DLPFC and of mood improvement, we
conducted a pilot study in 12 drug-resistant bipolar depressed
patients receiving either active or sham iTBS over the left DLPFC
for 1–3 weeks. Short-term TMS-induced neuromodulation was
tested by comparing performances to a saccadic task performed
just before and just after the iTBS session. It was expected that
AS performances would be better just after the iTBS session than
before for the iTBS active group and not for the sham group;
and that changes in AS performances would be stronger in the
contralateral hemifield of the stimulated DLPFC, i.e., here, the
right hemifield. The relevance of the AS task to assess patients’
mood improvement was analyzed by computing the correlation
between mood improvement and AS performance improvement.
Besides this, we examined the difference between depressed bipo-
lar patients and healthy controls; it was expected that before treat-
ment, patients’ AS performances would be impaired compared to
those of healthy subjects.
METHODS
EXPERIMENTAL DESIGN
Active or sham iTBS treatment was applied twice a day, 5 days a
week for 1–3 weeks. Two sessions of saccadic task were conducted
on the first day of each week (D0, D7, and D14), one session (S1)
before the iTBS and a second (S2) immediately following the iTBS
(Figure 1). To ensure that any improvement in the AS perfor-
mances could not be accounted for by a simple learning effect,
two training sessions were administered 4 days before (D-3) the
beginning of the iTBS treatment to minimize the practice-related
effects. Two sessions of the saccadic task were also performed at
the end of the protocol (D18).
SUBJECTS
Patient group
Twelve patients (6 females, 6 males; mean age 51.6 ± 11.7
years) with drug-resistant bipolar disorder (Types I, II, or III)
participated in this randomized double-blind placebo-controlled
iTBS study. The study was approved by the regional Ethics Com-
mittee (Committee for the Protection of Persons in biomedical
researches: CPP Sud-Est VI) and allowed by the ANSM (French
National Agency for Medicines and Health Products Safety)
(Authorization: 2010-A01085-34).
Patients were randomly assigned to the active or to the sham
group. This randomization was performed using a randomization
table and assessed 3 by 3 to have the same proportion of patients
in each group. As allowed by the protocol of the study, the
TMS operator did the un-blinding for the purpose of this study,
independently from the clinical research team, who remained
fully blind of each patient’s treatment status.
The inclusion criteria were having a drug-resistant major
depressive episode defined according to DSM IV-TR. The cri-
terion of severity was a score of over 20 with a maximum
of 60 on the Montgomery and Asberg Depression Rating Scale
(MADRS: Montgomery and Asberg, 1979) (see Table 1 for
details). Drug resistance was defined as the absence of a response
to any antidepressant treatment over at least a 4-week period
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FIGURE 1 | Experimental design (D = day, S1 and S2 = first and second
AS task sessions). On D-3 two AS task sessions are performed for
training purposes. Repetitive TMS treatment was administered every day
during the week but AS task sessions were performed only on the first day
of each week, immediately before (S1) or immediately after (S2) rTMS
treatment.
Table 1 | Individual MADRS scores arranged by Group (active vs.
sham) and day of treatment (beginning vs. end) and intergroup
comparisons.
Subjects Group MADRS MADRS Improvement
beginning end
1 Active 30 8 73.3%
2 Active 36 13 63.9%
3 Active 38 13 65.8%
4 Active 32 23 28.1%
5 Active 24 8 66.7%
6 Sham 24 5 79.2%
7 Sham 25 16 36%
8 Sham 37 9 75.7%
9 Sham 27 4 85.2%
10 Sham 32 11 65.6%
11 Sham 38 36 5%
12 Sham 25 14 44%
Inter-Group Comparisons
(m ± SD) t and p-values
Active vs. Sham (beginning) (32 ± 5 vs. 30 ± 6) 0.68 (0.51)
Active vs. Sham (end) (13 ± 6 vs. 14 ± 11) −0.10 (0.92)
Active vs. Sham (improvement) (60 ± 18 vs. 56 ± 29) 0.25 (0.81)
of time. Patients with a history of substance abuse and patients
who did not meet inclusion criteria for use of TMS and
MRI (no pacemaker, no history of epilepsy or other neuro-
logical disorders) were excluded. Mood-stabilizers were allowed
during the treatment period only if the patients were sta-
ble for at least 4 weeks before the rTMS treatment. Only
anxiolytic drugs (cyamemazine or hydroxyzine) at low doses
could be administered if necessary during the rTMS treatment
period.
Control group
Twelve control subjects (7 females, 5 males; mean age 50.6 ±
10.9 years) also participated in the study. These subjects had
no psychiatric history and were not taking any medication. This
group only performed one saccadic task session. Every participant
provided written, informed consent.
INTERMITTENT THETA BURST STIMULATION (iTBS)
The iTBS was applied using a figure-of-eight coil (MCF-B65-
H0) and an air-cooled stimulator (MagProX100, MagVenture).
For each patient the left DLPFC was delimited using three-
dimensional magnetic resonance imaging (3D-MRI). The TMS
coil was monitored throughout stimulations using a neuron-
avigation device (TMS Navigator, Localite). We used an iTBS
protocol in which a 2 s train of bursts containing three pulses
at 50 Hz was repeated at 200 ms (i.e., 5 Hz) every 10 s (Huang
et al., 2005), these parameters mimicked the theta rhythm in
EEG nomenclature. The TMS operators applied the iTBS twice
per day, with a minimum inter-session interval of 3 h every day
for 1–3 weeks depending of clinical relevance. For each rTMS
session 990 pulses were administered to give a total of 5 min
30 s of stimulation, thus, patients received 1980 pulses per day.
Patients were stimulated with either an active coil (active group:
n = 5) or a sham coil (sham group: n = 7). The sham coil made
the same “clicking” sound than the active coil, and produced a
weak magnetic field on the scalp for reproducing the same skin
sensation than the active coil.
We individually set the stimulation intensity at 80% of the
patient’s resting motor threshold (RMT), which we determined
3 days before the beginning of the iTBS treatment phase (D-3).
We began by placing three electrodes over the patient’s first
dorsal interosseous muscle (FDI) in a belly-tendon montage.
Electromyograms were amplified (1–10 K), band-pass filtered
(1–6 KHz), and sampled at 12 KHz using a Dantec Keypoint
portable system (Natus Medical Incorporated). We placed the
coil on the “hotspot”: the position on the motor cortex that
elicited the greatest motor-evoked potential (MEP) in the con-
tralateral FDI. We defined the RMT as the minimum stimu-
lation intensity needed to evoke a MEP greater than 50 µV
on at least 5 out of 10 consecutive trials (Rossini et al.,
1994).
SACCADIC TASK
We used an EyeLink 1000 video-based eye-tracking system (SR
Research) with a temporal resolution of 500 Hz. The eye-tracker
detects saccades automatically, using three thresholds: velocity
(30◦/s), acceleration (8000◦/s2), and saccadic motion (0.15◦).
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Stimuli were displayed on a computer screen located 57 cm from
the participants. The computer screen resolution was 1024 ×
768 pixels and the screen refresh rate was 85 Hz. Participants
were seated in a darkened room and their heads were stabilized
using chin rests. We used a SPAN task (Saccade: Pro, Anti and
No) which mixed three types of saccades: antisaccades (AS), no-
saccades (NS) and prosaccades (PS). PS was used to verify that the
bipolar patients did not suffer from a general deficit in saccadic
function. Additionally, compared to a traditional AS task, this
mixed saccadic paradigm increased the cognitive load in terms
of executive functions, and thus reinforced the implication of the
DLPFC (Smith and Jonides, 1999).
Each trial began with a 500 ms presentation of a white central
fixation dot, and then the central fixation dot became red, blue,
or green for 2 s. Participants were told to make a PS if it was
green, an AS if it was red, or an NS response if it was blue
(Figure 2). After this time, a blank screen was displayed for
a 200 ms gap, and a “cue”, the number “0”, was flashed for
50 ms at 10◦ peripherally (randomly on the right or left side
of the screen). During AS trials, patients had to look towards
the opposite side from the cue as quickly as possible in order
to identify a numeric target (“6” or “9”), which was presented
for 1 s beginning as soon as they looked at the correct location
(gaze-contingent display) or after a 2-s delay. During PS trials,
patients had to look as quickly as possible towards the side of
the cue to identify the numeric target. During NS trials, they
had to keep their gaze fixed on the center of the screen. There
was a break of 1 s between two successive trials. During the
first SPAN session, both patients and healthy controls received
20 practice trials and 80 test trials (16 NS trials, 32 PS trials, and
32 AS trials). In the following SPAN sessions, patients performed
80 test trials. We assessed the performances using the inhibition
error rate, i.e., the proportion of saccades towards the cue for AS
and NS trials and the latency of correct saccades for PS and AS
trials.
We analyzed the oculometric performance, i.e., the inhibi-
tion error rates and the saccadic reaction times using Matlab
(MATLAB, R2009b, The MathWorks Inc., Natick, MA, 2009) and
Statistica (Statistica 10, Statsoft Inc., 1984).
MOOD EVALUATION
We analyzed MADRS scores at the beginning and at the end of
the experiment in order to assess mood changes over the time
course of the experiment, as well as to assess responses to the iTBS
treatment. We defined “response to the treatment” when there was
a 50 % improvement of the MADRS score and “remission” when
the MADRS score became lower than 8.
RESULTS
In the following results we only present the inhibition error rates
in AS trials as we did not find any differences for PS, NS and
latencies of AS trials.
COMPARISON OF “HEALTHY SUBJECTS VS. DEPRESSIVE BIPOLAR
PATIENTS”
We performed an ANOVA on inhibition error rates with the
Group (bipolar patients (n = 12) and healthy controls (n = 12)) as
the between-subjects factor, and the Cue Position (left or right) as
the within-subjects factor. This comparison was performed on the
learning session only (D-3) for both groups. The ANOVA revealed
a main effect of the Group (F(1,22) = 4.8; p = 0.04). Patients
committed significantly more errors than did controls (26.9% vs.
13.8%). We did not find any effect of the Cue Position, nor of the
interaction Group× Cue Position (F(1,22) < 1).
SHORT-TERM iTBS NEUROMODULATION
We performed another ANOVA on inhibition error rates with
the Group” (active (n = 5) and sham (n = 7)) as the between-
subjects factor, and the Session (Session 1 and Session 2) as the
within-subjects factor. The ANOVA did not reveal any effect of
FIGURE 2 | Examples of trial sequences for the three trial types (red = AS, blue = NS, green = PS) (from Malsert et al., 2013).
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FIGURE 3 | Mean inhibition error rates on the AS task as a function of
the sessions (session 1 vs. session 2) and group (active vs. sham).
Errors bars represent standard error.
the Group (F(1,10) < 1). However, we found a main effect of the
Session (F(1,10) = 6.29; p = 0.03). Performances were improved in
session 2 compared to session 1 (24.2% vs. 19.9%). We also found
a significant interaction Group× Session (F(1,10) = 5.29; p = 0.04)
(Figure 3). Patients in the active group committed fewer errors in
session 2 than in session 1 (23.2% vs. 14.9%) (F(1,10) = 9.9; p =
0.01), while the performances of the patients in the sham group
did not show any improvements (25.1% vs. 24.8%) (F(1,10) < 1)
(Figure 3). When the cue was presented in the right hemifield
(contralateral field of iTBS neuromodulation), 100% of patients
in the active group improved their performances (vs. 57% of the
sham group).
EFFECTS OF MOOD IMPROVEMENT
The MADRS scores analyses did not reveal any differences
between the active and sham groups before the treatment (p =
0.51). After the treatment, four out of five patients in the active
group and four out of seven in the sham group responded to the
treatment i.e., showed an improvement of more than 50% on the
MADRS scores. The t-tests did not reveal any differences between
groups, neither on the MADRS scores nor for mood improvement
(Table 1). To assess the relevance of the AS task as a marker of
this mood improvement, we calculated the Pearson’s correlation
coefficient between the improvement in the MADRS scores and
the difference in inhibition error rates between the end and the
beginning of the treatment. We found a significant and positive
linear association (r = 0.65; p = 0.02; R2 = 0.42): better mood is
associated with better performance in AS (Figure 4).
DISCUSSION
This study investigated the AS task as a psychophysical tool to
assess the short-term neuromodulation that has been hypothe-
sized to be induced by daily iTBS delivered over the left DLPFC.
We also examined the ability of the AS task to discriminate
depressive bipolar patients from healthy subjects, and to be a
marker of mood improvement.
RELEVANCE OF AS TASK TO DISCRIMINATE DEPRESSED BIPOLAR
PATIENTS FROM HEALTHY SUBJECTS
Over the past three decades, there has been an increase in the
number of neuropsychophysical studies of saccadic performance
FIGURE 4 | Correlation between the improvements in MADRS scores
and inhibition error rate between the end and the beginning of the
rTMS treatment. Bravais-Pearson coefficient correlation coefficient equals
R = 0.65, p = 0.02 and R2 = 0.42, where R2 is the proportion of variance
explained by the regression model.
in psychiatric patient groups (Gooding and Basso, 2008). Some
authors suggested that performance on the AS task could be used
as a psychophysical marker for mood disorders (García-Blanco
et al., 2013; Malsert et al., 2013). Our results confirmed that
the AS task could discriminate depressed bipolar patients from
healthy subjects. We did not find any group differences on PS
performance, which means that depressive bipolar patients did
not suffer from a general impairment in saccadic function.
Maybe due to the small number of patients, our study did not
show group differences associated with the cue position, i.e., no
cerebral asymmetry. Whether depressed bipolar patients display
a cerebral asymmetry in the inhibitory functions of the DLPFC
is still being discussed in the literature (Clark et al., 2006; Savitz
and Drevets, 2009); it is a crucial issue since rTMS therapy is
often based on the premise that left DLPFC is hypoactive in
depression.
RELEVANCE OF AS TASK TO ASSESS SHORT-TERM iTBS-INDUCED
NEUROMODULATION OF THE DLPFC
Until now only one study investigated the AS performance during
rTMS treatment applied over the DLPFC to investigate the rTMS
neuromodulation effect of this cortical region (Crevits et al.,
2005). In their study, the left DLPFC of 11 depressed patients
was stimulated with 1000 pulses per day of facilitatory rTMS
(10 Hz). The treatment lasted for at least 10 sessions, with
no more than one session a day, over a maximum period of
3 weeks. The AS task was only performed twice: before the first
rTMS session and after the last rTMS session. They found a
significant decrease in AS latencies at the end of the treatment.
However, the absence of a control group of patients receiving
sham rTMS prevented the authors from drawing any conclusions
about the long-term effects of rTMS. Additionally, the latency
reduction in AS might have reflected a practice effect as the
AS task was being repeated at the end of the rTMS treatment.
Chauvin et al. (2011) studied the evolution of performance across
several sessions of an AS task and found that performance only
improved (with decreases in AS latency and inhibition error rate)
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over the two first sessions. Finally, mood improvement was able
to explain the AS performance improvement (Salvadore et al.,
2011).
In our knowledge, our study was the first research investigating
by oculometry the short-term iTBS-induced neuromodulation
of the DLPFC, using a neuronavigation system. As expected, we
observed an aftereffect of the iTBS sessions: only the patients in
the active group improved their capacity to inhibit the reflexive
saccades immediately after the iTBS sessions. This improvement
was consistently observed when the cue was presented in the right
hemifield, i.e., processed by the left DLPFC. These results provide
evidence that iTBS induces short-term neuromodulation of the
targeted cortical area. This means that the AS task could be a use-
ful instrument to ascertain whether short-term neuromodulation
induced by iTBS occurs.
RELEVANCE OF AS TASK AS A POTENTIAL MARKER OF MOOD
IMPROVEMENT
We found that the active and sham groups showed a similar
mood improvement. This improvement in the sham group and
possibly in the active group too was due to a placebo effect
(see Mayberg et al., 2002). Some studies showed that mood
improvement could result in cognitive improvement. Biringer
et al. (2005) showed that recovery from major unipolar depression
is associated with a recovery of many aspects of executive func-
tioning, improving executive functioning to a normal level. In
accordance with these studies, we found a significant correlation
between mood improvement and AS improvement. This indicates
that the saccadic task might not only be a useful marker of the
short-term neuromodulation, but a marker of mood changes
too.
CONCLUSION
This pilot study investigated the iTBS-induced short-term neu-
romodulation of the DLPFC. This is a crucial issue since little is
known about the aftereffect of TBS over the DLPFC while being
used in clinical research, in particular, with psychiatric disor-
ders (Soekadar et al., 2009; Chistyakov et al., 2010; Holzer and
Padberg, 2010; Plewnia et al., 2014). Exploring the rTMS/iTBS
aftereffects requires the development of an instrument to enable
one to objectively measure the short-term TBS-induced neuro-
modulation, which is the sine qua non condition to long-term
neuromodulation taking place (Pascual-Leone et al., 1994; Valero-
Cabré et al., 2011). Our study demonstrates that an AS task could
be used to assess it. Moreover, we confirmed that AS performance
could discriminate depressive bipolar patients from healthy sub-
jects and be used as a marker of mood variation (response to
treatment or relapse into illness) (Malsert et al., 2012b; Aleman,
2013).
However, due to the small sample size, our findings should
be replicated using a larger cohort of patients. Moreover,
the oculometric task could be improved by adding an emo-
tional component to increase the load imposed on the DLPFC
inhibitory control. Indeed, in humans, the existence of con-
nections between the DLPFC and the limbic regions is well
established, although the anatomical details of the connections
remain unclear in humans (Fox et al., 2012) and monkeys
(Petrides and Pandya, 1999). Adding emotional cues should
improve the psychometric relevance of the oculometric sessions
(García-Blanco et al., 2013). Using an implicit emotional ocu-
lometric paradigm every day with depressive bipolar patients
should enable a finer-grained analysis of short-term neuromod-
ulation induced by rTMS over the DLPFC and could be a way
to optimize and customize the TMS treatment by adjusting
rTMS parameters of each patient according to the obtained
post-effect.
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